000 | 01608 a2200457 4500 | ||
---|---|---|---|
005 | 20250511234804.0 | ||
264 | 0 | _c19900711 | |
008 | 199007s 0 0 eng d | ||
022 | _a0091-2700 | ||
024 | 7 |
_a10.1002/j.1552-4604.1990.tb03485.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLapierre, K A | |
245 | 0 | 0 |
_aThe neuropsychiatric effects of aspartame in normal volunteers. _h[electronic resource] |
260 |
_bJournal of clinical pharmacology _cMay 1990 |
||
300 |
_a454-60 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAffect _xdrug effects |
650 | 0 | 4 |
_aAmino Acids _xblood |
650 | 0 | 4 |
_aAspartame _xadministration & dosage |
650 | 0 | 4 |
_aBlood Glucose _xanalysis |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 |
_aDipeptides _xpharmacology |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemory _xdrug effects |
650 | 0 | 4 |
_aPhenylalanine _xblood |
650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aReaction Time _xdrug effects |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aGreenblatt, D J | |
700 | 1 | _aGoddard, J E | |
700 | 1 | _aHarmatz, J S | |
700 | 1 | _aShader, R I | |
773 | 0 |
_tJournal of clinical pharmacology _gvol. 30 _gno. 5 _gp. 454-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1552-4604.1990.tb03485.x _zAvailable from publisher's website |
999 |
_c2354035 _d2354035 |